Nutrient-Dense Complementary Foods on Catch-up Growth and Nutritional Status of Stunting Children
Stunting
About this trial
This is an interventional treatment trial for Stunting focused on measuring stunting, indonesia
Eligibility Criteria
Inclusion Criteria:
- identified as stunting (having HAZ ≤ -2SD of the WHO Growth Standard 2006)
- no clinical evidence of any acute infectious disease or other diseases or morbidity condition that could interfere with the intake of study diets
- parents and children residence in the study area.
- parental concent obtained
Exclusion Criteria:
- presence of oedema, severe illness warranting hospitalization on the enrolment day such as persistent diarrhea and other disease which may influence feeding practices and nutrient absorption
- conncurrent participation in another clinical trial
- severe anemia with hemoglobine concentration < 7.0 g/dL
Sites / Locations
- in the community (Woja,Manggelewa, Kempo subdistrict)
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Placebo Comparator
HND-CF
SND-CF
NDN-CF
subjects will receive nutrient dense complementary foods in optimized CFRs + fortified biscuit (ferrous fumarate 83.5 mg, zinc oxide 50.95 mg, Calcium carbonate 3104.05 mg, Thiamine Mononitrate1.85 mg, Nicotinic Acid 30.45 mg, Pyridoxine Hydrocloride 2.90 mg, Pteroyl monoglutamic acid 764.90 mcg, Cyanocobalamin 0.95 mcg, Retinol Palmitate (dry) 742.50 mcgRE)
subjects will receive nutrient dense complementary foods in optimized CFRs + fortified biscuit (ferrous fumarate 32.6 mg, zinc oxide 3.78 mg, Calcium carbonate 874.12 mg, Thiamine Mononitrate1.25 mg, Nicotinic Acid 17.95 mg, Pyridoxine Hydrocloride 1.10 mg, Pteroyl monoglutamic acid 329.90 mcg, Cyanocobalamin 0.55 mcg)
subjects will receive nutrient dense complementary foods in optimized CFRs + non fortified biscuit